Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 5 studies | 33% ± 14% | |
| B cell | 3 studies | 23% ± 2% | |
| CD4-positive, alpha-beta T cell | 3 studies | 22% ± 1% | |
| classical monocyte | 3 studies | 24% ± 3% | |
| non-classical monocyte | 3 studies | 26% ± 7% | |
| ciliated cell | 3 studies | 20% ± 2% | |
| fibroblast | 3 studies | 18% ± 4% | |
| dendritic cell | 3 studies | 28% ± 10% | |
| natural killer cell | 3 studies | 18% ± 1% |
Insufficient scRNA-seq data for expression of MRPL44 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 1277.72 | 226 / 226 | 100% | 46.19 | 406 / 406 |
| skin | 100% | 1337.06 | 1809 / 1809 | 100% | 107.97 | 472 / 472 |
| stomach | 100% | 878.90 | 359 / 359 | 100% | 53.57 | 286 / 286 |
| esophagus | 100% | 977.28 | 1444 / 1445 | 100% | 36.78 | 183 / 183 |
| breast | 100% | 1089.60 | 459 / 459 | 100% | 58.73 | 1116 / 1118 |
| prostate | 100% | 823.41 | 245 / 245 | 100% | 62.47 | 501 / 502 |
| intestine | 100% | 1120.30 | 966 / 966 | 100% | 62.65 | 525 / 527 |
| brain | 100% | 840.51 | 2630 / 2642 | 100% | 55.28 | 705 / 705 |
| ovary | 99% | 794.49 | 179 / 180 | 100% | 50.40 | 430 / 430 |
| pancreas | 99% | 628.70 | 326 / 328 | 100% | 46.03 | 178 / 178 |
| uterus | 100% | 841.17 | 170 / 170 | 99% | 48.22 | 456 / 459 |
| thymus | 100% | 891.82 | 653 / 653 | 99% | 43.34 | 601 / 605 |
| lung | 99% | 848.00 | 572 / 578 | 100% | 50.19 | 1155 / 1155 |
| bladder | 100% | 826.24 | 21 / 21 | 99% | 48.02 | 498 / 504 |
| kidney | 100% | 1469.27 | 89 / 89 | 99% | 59.02 | 890 / 901 |
| adrenal gland | 100% | 1924.07 | 258 / 258 | 95% | 41.04 | 219 / 230 |
| adipose | 100% | 1119.93 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 138.20 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 105.12 | 29 / 29 |
| muscle | 100% | 1656.42 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1288.55 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 51.97 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 22.05 | 1 / 1 |
| blood vessel | 100% | 759.90 | 1329 / 1335 | 0% | 0 | 0 / 0 |
| heart | 97% | 1232.64 | 837 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 94% | 1367.62 | 871 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0032543 | Biological process | mitochondrial translation |
| GO_0070125 | Biological process | mitochondrial translational elongation |
| GO_0006396 | Biological process | RNA processing |
| GO_0005743 | Cellular component | mitochondrial inner membrane |
| GO_0005762 | Cellular component | mitochondrial large ribosomal subunit |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0016604 | Cellular component | nuclear body |
| GO_0070877 | Cellular component | microprocessor complex |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005634 | Cellular component | nucleus |
| GO_0004525 | Molecular function | ribonuclease III activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0003725 | Molecular function | double-stranded RNA binding |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | MRPL44 |
| Protein name | Large ribosomal subunit protein mL44 (EC 3.1.26.-) (39S ribosomal protein L44, mitochondrial) (L44mt) (MRP-L44) |
| Synonyms | |
| Description | FUNCTION: Component of the 39S subunit of mitochondrial ribosome. May have a function in the assembly/stability of nascent mitochondrial polypeptides exiting the ribosome. . |
| Accessions | Q9H9J2 ENST00000258383.4 |
